GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 793 filers reported holding GLAXOSMITHKLINE PLC in Q2 2018. The put-call ratio across all filers is 0.67 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $361,000 | -1.4% | 8,296 | 0.0% | 0.06% | 0.0% |
| Q4 2021 | $366,000 | -1.9% | 8,296 | -15.1% | 0.06% | -6.2% |
| Q3 2021 | $373,000 | +5.7% | 9,771 | +10.3% | 0.06% | +4.8% |
| Q2 2021 | $353,000 | -9.0% | 8,862 | -18.4% | 0.06% | -13.9% |
| Q1 2021 | $388,000 | -14.0% | 10,862 | -11.3% | 0.07% | -20.9% |
| Q4 2020 | $451,000 | -22.6% | 12,247 | -20.9% | 0.09% | -34.1% |
| Q3 2020 | $583,000 | -7.3% | 15,492 | +0.5% | 0.14% | -15.3% |
| Q2 2020 | $629,000 | -0.9% | 15,422 | -8.0% | 0.16% | -22.0% |
| Q1 2020 | $635,000 | -18.0% | 16,772 | +1.9% | 0.21% | +6.1% |
| Q4 2019 | $774,000 | +18.7% | 16,462 | +7.7% | 0.20% | +5.9% |
| Q3 2019 | $652,000 | +8.3% | 15,287 | +1.7% | 0.19% | +7.5% |
| Q2 2019 | $602,000 | -6.7% | 15,037 | -2.6% | 0.17% | -6.0% |
| Q1 2019 | $645,000 | +6.6% | 15,437 | -2.5% | 0.18% | -6.1% |
| Q4 2018 | $605,000 | -6.1% | 15,837 | -1.2% | 0.20% | +12.6% |
| Q3 2018 | $644,000 | -19.9% | 16,037 | -19.6% | 0.17% | -23.0% |
| Q2 2018 | $804,000 | +3.2% | 19,937 | 0.0% | 0.23% | +2.3% |
| Q1 2018 | $779,000 | +10.2% | 19,937 | 0.0% | 0.22% | +12.2% |
| Q4 2017 | $707,000 | -33.2% | 19,937 | -23.6% | 0.20% | -35.8% |
| Q3 2017 | $1,059,000 | -20.2% | 26,087 | -15.3% | 0.31% | -24.0% |
| Q2 2017 | $1,327,000 | +3.6% | 30,787 | +1.3% | 0.40% | -0.5% |
| Q1 2017 | $1,281,000 | +8.5% | 30,387 | -1.0% | 0.41% | -0.5% |
| Q4 2016 | $1,181,000 | -15.2% | 30,687 | -5.0% | 0.41% | -18.7% |
| Q3 2016 | $1,392,000 | +3.2% | 32,287 | +3.7% | 0.50% | -1.8% |
| Q2 2016 | $1,349,000 | +7.2% | 31,137 | +0.3% | 0.51% | +5.8% |
| Q1 2016 | $1,258,000 | +1.1% | 31,037 | +0.6% | 0.48% | -1.6% |
| Q4 2015 | $1,244,000 | -24.6% | 30,837 | -28.2% | 0.49% | -8.4% |
| Q3 2015 | $1,650,000 | -7.7% | 42,937 | -0.0% | 0.54% | +2.3% |
| Q2 2015 | $1,788,000 | -10.4% | 42,947 | -0.7% | 0.52% | -11.8% |
| Q1 2015 | $1,995,000 | +9.7% | 43,244 | +1.7% | 0.59% | +10.4% |
| Q4 2014 | $1,818,000 | -9.6% | 42,541 | -2.8% | 0.54% | -11.8% |
| Q3 2014 | $2,012,000 | -11.2% | 43,788 | +3.3% | 0.61% | -11.2% |
| Q2 2014 | $2,266,000 | +35.6% | 42,387 | +35.5% | 0.69% | +28.2% |
| Q1 2014 | $1,671,000 | +0.1% | 31,287 | 0.0% | 0.54% | -5.5% |
| Q4 2013 | $1,670,000 | +7.8% | 31,287 | +1.3% | 0.57% | +4.4% |
| Q3 2013 | $1,549,000 | +2.0% | 30,887 | +1.6% | 0.54% | -1.5% |
| Q2 2013 | $1,518,000 | – | 30,387 | – | 0.55% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |